Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_3
3
43%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Other(3)

Detailed Status

unknown3
Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (60.0%)
N/A2 (40.0%)

Trials by Status

recruiting114%
unknown343%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7